Citigroup's Underestimated Rebound: Why Q2 Earnings Could Be an Inflection Point

Related Articles

Has Xeris Biopharma Reached an Inflection Point

5 months ago

Has China's EV Market Reached an Inflection Point for BYD

8 months ago

Has Genasys (GNSS) Finally Reached an Inflection Point

6 months ago

General Mills' Q4 Beat: An Inflection Point in a Price-Sensitive Market

4 months ago

Category

You may also like

Stock News•1 months ago

Here's How to Play Citigroup Stock Ahead of Q3 Earnings Release

Citigroup's Q3'26 results are expected to benefit from higher net interest income and market revenues, with cost savings and capital returns as key focus areas.

C

Share

Stock News•4 months ago

Citigroup: A Comeback For The Ages Continues

Citigroup Q2 revenues rose 14% YoY with broad-based segment strength, driving a 61% surge in diluted EPS. The efficiency ratio improved to 57.4%, while a 12% dividend hike and $30B buyback signal conf...

C

Share

Stock News•4 months ago

Citigroup: Traders Are Getting Too Excited About Capital Markets Growth (Rating Downgrade)

Citigroup shares may be overvalued after recent gains, as strong Q2 earnings expectations are already priced in. Profitability metrics don't support a higher P/E multiple or premium to book value.

C

Share